The findings from this study revealed that ZEB1-AS1 silencing down-regulated ZEB1 by elevating miR-129-5p, thus decreasing drug resistance to cisplatin and promoting cell apoptosis in breast cancer, which might serve as the theoretical foundation for the development of new therapeutic targets and provide potential tumor chemosensitizer in breast cancer treatment. Here, ZEB1 is linked to breast cancer.